Katsuyoshi Akiyama, PhD.

Katsuyoshi Akiyama, PhD. is the Director of Business Development at C4U Corporation, a biotech company based in Osaka, Japan.12 C4U focuses on developing safe and efficient gene therapies using their proprietary CRISPR-Cas3 gene editing platform.2

Dr. Akiyama's role involves overseeing business development activities for C4U, which includes:

1. Establishing strategic partnerships and collaborations with other companies and research institutions
2. Exploring potential applications of C4U's CRISPR-Cas3 technology in various fields
3. Representing the company in business negotiations and agreements

Some key points about Dr. Akiyama and C4U:

• C4U is working on gene therapies for rare diseases, including pediatric conditions.2
• The company's CRISPR-Cas3 platform offers advantages such as improved safety through reduced unintended mutations and the ability to make large gene alterations.1
• C4U has entered into collaborations with companies like The Center for Aquaculture Technologies (CAT) to apply their technology in areas such as aquaculture.1
• They have also formed a strategic alliance with Healiva SA to develop CRISPR-Cas3 derived therapeutic solutions for Epidermolysis Bullosa.2

Dr. Akiyama's educational background includes studying at Kanazawa University.3 His LinkedIn profile indicates he has 473 connections, suggesting he is well-networked within the biotech and gene therapy industries.3